• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年慢性阻塞性肺疾病 10 年生存者的 FEV 年变化率。

Annual change in FEV in elderly 10-year survivors with established chronic obstructive pulmonary disease.

机构信息

Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Center for Respiratory Diseases, JCHO Hokkaido Hospital, Sapporo, Japan.

出版信息

Sci Rep. 2019 Feb 14;9(1):2073. doi: 10.1038/s41598-019-38659-8.

DOI:10.1038/s41598-019-38659-8
PMID:30765818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375910/
Abstract

Long-term decline in lung function is generally considered to be progressive in individuals with established chronic obstructive pulmonary disease (COPD), despite the presence of intersubject variation. We hypothesized that the annualized rate of decline in forced expiratory volume in 1 second (FEV) would not be constant among different time periods in the natural history of established COPD. We compared the annual change rates in FEV during the first 5 years and the last 5 years, estimated separately using a linear mixed-effects model in 10-year survivors (n = 110). The subjects were classified into three FEV decline groups, based on the 25th and 75th percentile values in each time period. The rates of FEV changes, calculated from the first 5 years and the last 5 years, did not correlate with each other among 10-year survivors; the subjects of each FEV decline group during the first 5 years did not consistently remain in the same FEV decline group during the last 5 years. Smoking status and exacerbation frequency were not associated with decline in FEV. In conclusion, the disease activity, which is often expressed as annualized change in FEV, might be changeable either way over years in patients with established COPD.

摘要

长期以来,人们普遍认为,在已经确诊的慢性阻塞性肺疾病(COPD)患者中,肺功能下降是渐进的,尽管存在个体间的差异。我们假设,在已确诊 COPD 的自然史的不同时间段中,第 1 秒用力呼气量(FEV)的年下降率不会保持不变。我们使用线性混合效应模型,对 10 年幸存者(n=110)分别在最初 5 年和最后 5 年的 FEV 年变化率进行了比较。根据每个时间段的第 25 和 75 百分位值,将受试者分为三个 FEV 下降组。在 10 年幸存者中,从最初 5 年和最后 5 年计算得出的 FEV 变化率彼此之间没有相关性;最初 5 年每个 FEV 下降组的受试者在最后 5 年期间并不始终保持在相同的 FEV 下降组。吸烟状况和加重频率与 FEV 下降无关。总之,在已经确诊的 COPD 患者中,疾病活动度(通常以 FEV 的年变化率来表示)可能在几年内以任意方式发生变化。

相似文献

1
Annual change in FEV in elderly 10-year survivors with established chronic obstructive pulmonary disease.老年慢性阻塞性肺疾病 10 年生存者的 FEV 年变化率。
Sci Rep. 2019 Feb 14;9(1):2073. doi: 10.1038/s41598-019-38659-8.
2
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.
3
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.哥本哈根城市心脏研究中哮喘、慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠患者的长期预后:一项前瞻性基于人群的分析。
Lancet Respir Med. 2016 Jun;4(6):454-62. doi: 10.1016/S2213-2600(16)00098-9. Epub 2016 Apr 6.
4
Effect of a single exacerbation on decline in lung function in COPD.单次加重对慢性阻塞性肺疾病肺功能下降的影响。
Respir Med. 2017 Jul;128:85-91. doi: 10.1016/j.rmed.2017.04.013. Epub 2017 Apr 24.
5
Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者中按全球慢性阻塞性肺疾病倡议(GOLD)分组的肺功能下降率
Int J Chron Obstruct Pulmon Dis. 2015 Sep 7;10:1819-27. doi: 10.2147/COPD.S87766. eCollection 2015.
6
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺功能和临床表型的年度变化。
Am J Respir Crit Care Med. 2012 Jan 1;185(1):44-52. doi: 10.1164/rccm.201106-0992OC.
7
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].[采用层次聚类分析和两步聚类分析对症状性慢性气道疾病临床表型的研究]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.
8
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.导致慢性阻塞性肺疾病的肺功能轨迹。
N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532.
9
Longitudinal decline in lung function: a community-based cohort study in Korea.肺功能的纵向下降:韩国的一项基于社区的队列研究。
Sci Rep. 2019 Sep 20;9(1):13614. doi: 10.1038/s41598-019-49598-9.
10
Decline in FEV and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency.严重的α-1 抗胰蛋白酶缺乏症个体的 FEV 下降和住院加重。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1075-1083. doi: 10.2147/COPD.S195847. eCollection 2019.

引用本文的文献

1
Investigation of time profile of FEV across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan.潜在 COPD 发病过程中 FEV 时间特征的研究:使用日本体检数据的回顾性队列研究。
Sci Rep. 2023 Apr 3;13(1):5454. doi: 10.1038/s41598-023-32205-3.
2
Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease.特征与慢性阻塞性肺疾病初级保健人群肺功能加速下降相关。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 25;15:3079-3091. doi: 10.2147/COPD.S278981. eCollection 2020.
3
Unique Mortality Profile in Japanese Patients with COPD: An Analysis from the Hokkaido COPD Cohort Study.

本文引用的文献

1
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.儿童时期肺功能轨迹与未来 COPD 风险的预测因素:一项前瞻性队列研究,从生命的第一个十年到第六个十年。
Lancet Respir Med. 2018 Jul;6(7):535-544. doi: 10.1016/S2213-2600(18)30100-0. Epub 2018 Apr 5.
2
Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.慢性阻塞性肺疾病的哮喘样特征和临床病程。北海道 COPD 队列研究的分析。
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1358-1365. doi: 10.1164/rccm.201602-0353OC.
3
日本 COPD 患者的独特死亡率特征:北海道 COPD 队列研究分析。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 4;15:2081-2090. doi: 10.2147/COPD.S264437. eCollection 2020.
4
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease.2型炎症生物标志物在慢性阻塞性肺疾病中的作用
J Clin Med. 2020 Aug 18;9(8):2670. doi: 10.3390/jcm9082670.
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
导致慢性阻塞性肺疾病的肺功能轨迹。
N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532.
4
Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study.北海道 COPD 队列研究中 COPD 加重的临床特征和决定因素。
Eur Respir J. 2014 May;43(5):1289-97. doi: 10.1183/09031936.00110213. Epub 2013 Nov 14.
5
Lung function decline in COPD.COPD 中的肺功能下降。
Int J Chron Obstruct Pulmon Dis. 2012;7:95-9. doi: 10.2147/COPD.S27480. Epub 2012 Feb 9.
6
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺功能和临床表型的年度变化。
Am J Respir Crit Care Med. 2012 Jan 1;185(1):44-52. doi: 10.1164/rccm.201106-0992OC.
7
Changes in forced expiratory volume in 1 second over time in COPD.COPD 患者 1 秒用力呼气容积随时间的变化。
N Engl J Med. 2011 Sep 29;365(13):1184-92. doi: 10.1056/NEJMoa1105482. Epub 2011 Sep 26.
8
The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.慢性阻塞性肺疾病的进展是异质的:BODE 队列的经验。
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1015-21. doi: 10.1164/rccm.201105-0831OC.
9
Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently.急需用于疾病活动的慢性阻塞性肺疾病生物标志物。
Am J Respir Crit Care Med. 2010 Oct 1;182(7):863-4. doi: 10.1164/rccm.201004-0602ED.
10
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病的4年试验。
N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.